FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100120116> ?p ?o ?g. }

• W3100120116 endingPage "e037947" @default.
• W3100120116 startingPage "e037947" @default.
• W3100120116 abstract "Introduction Vasodilatory hypotension is common among intensive care unit (ICU) patients; vasopressors are considered standard of care. However, optimal mean arterial pressure (MAP) targets for vasopressor titration are unknown. The objective of the Optimal VAsopressor TitraTION in patients 65 years and older (OVATION-65) trial is to ascertain the effect of permissive hypotension (vasopressor titration to achieve MAP 60–65 mm Hg) versus usual care on biomarkers of organ injury in hypotensive patients aged ≥65 years. Methods and analysis OVATION-65 is an allocation-concealed randomised trial in 7 Canadian hospitals. Eligible patients are ≥65 years of age, in an ICU with vasodilatory hypotension, receiving vasopressors for ≤12 hours to maintain MAP ≥65 mm Hg during or after adequate fluid resuscitation, and expected to receive vasopressors for ≥6 additional hours. Patients are excluded for any of the following: active treatment for spinal cord or acute brain injury; vasopressors given solely for bleeding, ventricular failure or postcardiopulmonary bypass vasoplegia; withdrawal of life-sustaining treatments expected within 48 hours; death perceived as imminent; previous enrolment in OVATION-65; organ transplant within the last year; receiving extracorporeal life support or lack of physician equipoise. Patients are randomised to permissive hypotension versus usual care for up to 28 days. The primary outcome is high-sensitivity troponin T, a biomarker of cardiac injury, on day 3. Secondary outcomes include biomarkers of injury to other organs (brain, liver, intestine, skeletal muscle); lactate (a biomarker of global tissue dysoxia); resource utilisation; adverse events; mortality (90 days and 6 months) and cognitive function (6 months). Assessors of biomarkers, mortality and cognitive function are blinded to allocation. Ethics and dissemination This protocol has been approved at all sites. Consent is obtained from the eligible patient, the substitute decision-maker if the patient is incapable, or in a deferred fashion where permitted. End-of-grant dissemination plans include presentations, publications and social media platforms and discussion forums. Trial registration number NCT03431181 ." @default.
• W3100120116 created "2020-11-23" @default.
• W3100120116 creator A5000611437 @default.
• W3100120116 creator A5003074300 @default.
• W3100120116 creator A5008238381 @default.
• W3100120116 creator A5008261224 @default.
• W3100120116 creator A5011601803 @default.
• W3100120116 creator A5014892458 @default.
• W3100120116 creator A5019000744 @default.
• W3100120116 creator A5019675244 @default.
• W3100120116 creator A5021691828 @default.
• W3100120116 creator A5022809026 @default.
• W3100120116 creator A5023691164 @default.
• W3100120116 creator A5035871871 @default.
• W3100120116 creator A5037956429 @default.
• W3100120116 creator A5040014597 @default.
• W3100120116 creator A5041580507 @default.
• W3100120116 creator A5046860959 @default.
• W3100120116 creator A5050511897 @default.
• W3100120116 creator A5055074960 @default.
• W3100120116 creator A5055539825 @default.
• W3100120116 creator A5056509932 @default.
• W3100120116 creator A5057351951 @default.
• W3100120116 creator A5061090915 @default.
• W3100120116 creator A5063826921 @default.
• W3100120116 creator A5066198852 @default.
• W3100120116 creator A5069849817 @default.
• W3100120116 creator A5080458138 @default.
• W3100120116 creator A5082185641 @default.
• W3100120116 creator A5086669379 @default.
• W3100120116 creator A5089550922 @default.
• W3100120116 date "2020-11-01" @default.
• W3100120116 modified "2023-10-16" @default.
• W3100120116 title "Optimal VAsopressor TitraTION in patients 65 years and older (OVATION-65): protocol and statistical analysis plan for a randomised clinical trial" @default.
• W3100120116 cites W127034668 @default.
• W3100120116 cites W1898928487 @default.
• W3100120116 cites W2006893337 @default.
• W3100120116 cites W2007790231 @default.
• W3100120116 cites W2015103419 @default.
• W3100120116 cites W2016948481 @default.
• W3100120116 cites W2017696956 @default.
• W3100120116 cites W2021287136 @default.
• W3100120116 cites W2029992744 @default.
• W3100120116 cites W2036983910 @default.
• W3100120116 cites W2047747888 @default.
• W3100120116 cites W2060654077 @default.
• W3100120116 cites W2071637551 @default.
• W3100120116 cites W2075972250 @default.
• W3100120116 cites W2079775834 @default.
• W3100120116 cites W2093274439 @default.
• W3100120116 cites W2093671650 @default.
• W3100120116 cites W2096350581 @default.
• W3100120116 cites W2104672570 @default.
• W3100120116 cites W2108153775 @default.
• W3100120116 cites W2127842758 @default.
• W3100120116 cites W2152750226 @default.
• W3100120116 cites W2162109366 @default.
• W3100120116 cites W2164186760 @default.
• W3100120116 cites W2165291399 @default.
• W3100120116 cites W2267627681 @default.
• W3100120116 cites W2286228001 @default.
• W3100120116 cites W2287296216 @default.
• W3100120116 cites W2316360511 @default.
• W3100120116 cites W2318875567 @default.
• W3100120116 cites W2324829729 @default.
• W3100120116 cites W2328857825 @default.
• W3100120116 cites W2418215637 @default.
• W3100120116 cites W2463487848 @default.
• W3100120116 cites W2467133095 @default.
• W3100120116 cites W2517641494 @default.
• W3100120116 cites W2528556615 @default.
• W3100120116 cites W2572424620 @default.
• W3100120116 cites W2586383454 @default.
• W3100120116 cites W2595322131 @default.
• W3100120116 cites W2597070792 @default.
• W3100120116 cites W2613803828 @default.
• W3100120116 cites W2775883273 @default.
• W3100120116 cites W2905222394 @default.
• W3100120116 cites W2925263181 @default.
• W3100120116 cites W2944434778 @default.
• W3100120116 cites W2952762910 @default.
• W3100120116 cites W2962931983 @default.
• W3100120116 cites W2999905014 @default.
• W3100120116 cites W3005570206 @default.
• W3100120116 cites W3016555942 @default.
• W3100120116 cites W4233323540 @default.
• W3100120116 cites W4240468586 @default.
• W3100120116 cites W4253738252 @default.
• W3100120116 doi "https://doi.org/10.1136/bmjopen-2020-037947" @default.
• W3100120116 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7668371" @default.
• W3100120116 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33191251" @default.
• W3100120116 hasPublicationYear "2020" @default.
• W3100120116 type Work @default.
• W3100120116 sameAs 3100120116 @default.
• W3100120116 citedByCount "3" @default.
• W3100120116 countsByYear W31001201162022 @default.
• W3100120116 crossrefType "journal-article" @default.
• W3100120116 hasAuthorship W3100120116A5000611437 @default.

• next